| ODN2041-1
| ODN 2041-Non-CpG ODN. Invitro control for rabbit cells. Antigen grade |
1 mg |
768 € |
adi |
human |
| ATODN1-1
| AT ODN-Non-CpG AT rich ODN. TLR9 agonist.-Antigen grade |
100 μg |
333 € |
adi |
human |
| ATODN2-1
| AT ODN-Non-CpG AT rich ODN. TLR9 agonist.-Antigen grade |
100 μg |
333 € |
adi |
human |
| ATODN3-1
| AT ODN-Non-CpG AT rich ODN. TLR9 agonist.-Antigen grade |
100 μg |
333 € |
adi |
human |
| ODN006-1
| ODNBW006 Type B CpG ODN structure feature at the 5' and A-type CpG ODN structure feature at the 3' end |
1 mg |
768 € |
adi |
human |
| ODNINH47-1
| ODN INH-47-Class R (restricted) inhibitory ODN TLR9 Antagonist-Palindromic variant of ODN INH-1-antigen grade |
200 μg |
260 € |
adi |
human |
| MBS614828
| MBD2a (Methyl CpG Binding Domain Protein 2a, Demethylase, DMTase, DKFZp586O0821, MBD2, Methyl CpG Binding Domain Protein 2 Isoform 1, Methyl CpG Binding Protein MBD2, NY-CO-41) Antibody |
100ul |
763 € |
MBS Polyclonals_1 |
human |
| GENTAUR-58bd15989d965
| Archaeoglobus fulgidus Uncharacterized protein AF_2041 (AF_2041) |
1000ug |
1470 € |
MBS Recombinant Proteins |
human |
| GENTAUR-58bd159be39c8
| Archaeoglobus fulgidus Uncharacterized protein AF_2041 (AF_2041) |
1000ug |
1978 € |
MBS Recombinant Proteins |
human |
| GENTAUR-58bcd7bd64375
| Sulfolobus islandicus UPF0095 protein M1425_2041 (M1425_2041) |
100ug |
2133 € |
MBS Recombinant Proteins |
human |
| GENTAUR-58bcd7bdaaf67
| Sulfolobus islandicus UPF0095 protein M1425_2041 (M1425_2041) |
1000ug |
2133 € |
MBS Recombinant Proteins |
human |
| GENTAUR-58bcd7bdf2da6
| Sulfolobus islandicus UPF0095 protein M1425_2041 (M1425_2041) |
100ug |
2647 € |
MBS Recombinant Proteins |
human |
| GENTAUR-58bcd7bf655ca
| Sulfolobus islandicus UPF0095 protein M1425_2041 (M1425_2041) |
1000ug |
2647 € |
MBS Recombinant Proteins |
human |
| ODN-NT-1
| Neutral ODN control ODN without agonistic nor antagonistic activity antigen grade |
100 μg |
768 € |
adi |
human |
| ODN-PK-5
| TLR9-B class agonist kit, Contains 100 ug of - ODN1668-1; ODN1826;and ODN2006 - ODN BW006 - B class, human/mouse - ODN 2007 - B-class, bovine/porcine - ODN D-SL01 |
1 pk |
550 € |
adi |
human |
| ODNDSL03-1
| Type B CpG ODN and a TLR9 agonist, antigen grade |
200 µg |
260 € |
adi |
human |
| ODNDSL01-1
| Type C CpG ODN and a TLR9 agonist, antigen grade |
200 µg |
260 € |
adi |
human |
| ODNIHN1-1
| ODN INH-1-Class R (restricted) inhibitory ODN-TLR 9 Antagonist-antigen grade |
200 μg |
260 € |
adi |
human |
| ODNINH18-1
| ODN INH-18 class R (‘restricted’) inhibitory ODN-TLR9 antagonist antigen grade |
200 µg |
260 € |
adi |
human |
| ODNM362-1
| ODN M362-Type C human/murine TLR9 agonist-antigen grade-antigen grade |
1 mg |
768 € |
adi |
human |
| ODNM362-5
| ODN M362-Type C human/murine TLR9 agonist-antigen grade-antigen grade |
5 mg |
2363 € |
adi |
human |
| MBS612715
| MIZF (MBD2 Interacting Zinc Finger Protein, Methyl CpG Binding Protein 2 Interacting Zinc Finger Protein, MBD2 (Methyl-CpG-Binding Protein)-Interacting Zinc Finger Protein) Antibody |
200ul |
558 € |
MBS Polyclonals_1 |
human |
| ODN1585-1NC
| ODN 1585-Type A murine TLR9 agonist (Negative Control), antigen grade |
1 mg |
695 € |
adi |
human |
| ODN1585-5NC
| ODN 1585-Type A murine TLR9 agonist (Negative Control), antigen grade |
5 mg |
1928 € |
adi |
human |
| ODN1668-1NC
| ODN 1668- Type B murine TLR9 Agonist (Negative Control), antigen grade |
1 mg |
695 € |
adi |
human |
| ODN1668-5NC
| ODN 1668- Type B murine TLR9 Agonist (Negative Control), antigen grade |
5 mg |
1928 € |
adi |
human |
| ODN1826-1NC
| ODN 1826- Type B murine TLR9 Agonist (Negative Control), antigen grade |
1 mg |
695 € |
adi |
human |
| ODN1826-5NC
| ODN 1826- Type B murine TLR9 Agonist (Negative Control), antigen grade |
5 mg |
1928 € |
adi |
human |
| ODN2006-1NC
| ODN 2006- Type B human TLR9 Agonist (Negative Control), antigen grade |
1 mg |
695 € |
adi |
human |
| ODN2006-5NC
| ODN 2006- Type B human TLR9 Agonist (Negative Control), antigen grade |
5 mg |
1928 € |
adi |
human |